BMI1 and neoplasm: Two studies agreed that BMI1 expression is a negative prognostic variable in AdCC, correlated significantly with increased tumor size [24], higher tumor stage [24], presence of distant metastasis [24,53], and shorter overall and disease-free survival [24], while prognostic significance was not confirmed in three other studies including AdCC cases (Table S5).